Are US Steel Stocks a 'Sell' after Disappointing Q1 Guidance?Steel stocksToday, Steel Dynamics (STLD) released its first-quarter earnings guidance. The company expects its first-quarter EPS to be between $0.88 and $0.92. It posted EPS of $1.17 in
Plastics Processing Machinery Market Plastics Processing Machinery Market Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Plastics Processing Machinery - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Plastics Processing Machinery Market to Reach $32.7 Billion by 2030The global market for Plastics Processing Machinery estimated at US$22.5 Billion in the year 2022, is projected to reach a revised size of US$32.7 Billion by 2030, growing at a CA
WisdomTree Issuer plc – Daily Fund Prices 25-April-24 WisdomTree Artificial Intelligence UCITS ETF - USD Acc24/04/2024IE00BDVPNG1314054630USD845,390,073.4960.1503WisdomTree AT1 CoCo Bond UCITS ETF - EUR Hedged24/04/2024IE00BFNNN2361662036EUR135,999,021.0681.8268WisdomTree Artificial Intelligence UCITS ETF - USD Acc25/04/2024IE00BDVPNG1314054630USD840,758,011.8659.8207WisdomTree AT1 CoCo Bond UCITS ETF - EUR Hedged25/04/2024IE00BFNNN2361662036EUR135,740,932.7481.6715WisdomTree AT1 CoCo Bond UCITS
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeMattioli Woods Plc(c) Name of the party to the offer with which exempt principal trader is co
The German driver joined Haas last year but will leave the American-owned team at the end of the season
ANNOUNCEMENT A.P. Møller - Mærsk A/S - Development of the Extraordinary General Meeting on Friday 26 April 2024 The Extraordinary General Meeting of A.P. Møller - Mærsk A/S took place on Friday 26 April 2024 as a completely electronic general meeting in accordance with the below agenda. The Board of Directors had appointed Niels Kornerup, attorney-at-law, as chair of the meeting. Agenda Completion of the demerger. The General Meeting adopted the Board’s proposal to complete the demerger of A.P.
ESPOO, Finland, April 26, 2024--Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced its financial results for the first quarter of 2024, demonstrating solid growth with a 4.7% increase in revenue. The company maintained its momentum in driving global sales of its digital platform, in the first quarter of 2024, completing many AIML and digital transformations to key customers, resulting in a significant increase in revenue. The growt
Global stocks were teetering on Friday towards their worst month since September, although futures markets predicted strong tech earnings would spark a Wall Street relief rally later in the day that would help traders recoup some losses. Japan's yen was volatile, hitting a fresh 34-year low after the Bank of Japan (BOJ) kept monetary policy loose at its latest policy meeting, then rebounding.
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeAccrol Group Holdings Plc(c) Name of the party to the offer with which exempt principal trade
Annual General Meeting 26th April 2023 Idavang A/S CVR 30 95 61 43 The agenda of the annual meeting of shareholders Election of chairman for the annual meeting of shareholdersPresentation of the annual report along with any director’s report and adoption of the annual reportResolution on the distribution of the profit recorded in the adopted annual reportElection of directors 5 existing members of the boards nominated (Niels Hermansen, Ole Bjerremand Hansen, Carsten Lund Thomsen, Jytte Rosenmaj
Annual account 2023 Please find enclosed the full annual account for Idavang A/S in pdf No changes in financial figures compared to Q4 report published end February If you wish to download the annual account file : IDAVANG-2023-12-31-en Please use the following link bit.ly/Idavang2023 Attachments Company announcement no 7 2024 Zip file Idavang Annual Report 2023
Everything you need to know about the difference between Rwanda and Congo - and the war between them
The yen rose sharply after hitting its weakest level in three decades against the U.S. dollar with markets on edge about possible intervention after the Bank of Japan kept interest rates on hold on Friday. The sudden jump left traders on high alert for signs of intervention. After a two-day meeting, the Bank of Japan left its short-term interest rate target at 0-0.1% on Friday and made small upward adjustments in its inflation forecast.
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "REM Poisoning - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering. This report outlays comprehensive insights of present clinical development scenario and growth prospects across the REM Poisoning market. A detailed picture of the REM poisoning pipeline landscape is provided, which includes the disease overview and REM poisoning treatment guidelines. The assessment part of the report embraces in-depth REM Po
Two men, both aged 22, are charged with immigration offences
Five migrants, including a child, were killed in a crush on board a boat crossing the Channel.
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Seborrhea - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. Seborrhea, a chronic skin condition often associated with oily skin and scalp, affects a significant portion of the global population, contributing to both physical discomfort and social stigma. Despite the availability of treatments, the need for more effective and targeted therapies persists. The report unveils detailed insights into the emerging drug
FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloserDimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in th
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Glioblastoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest report on the Glioblastoma pipeline insights covers extensive research into the promising therapeutic candidates for the treatment of Glioblastoma multiforme (GBM), an aggressive central nervous system tumor with an urgent need for improved therapies. Current and Future Glioblastoma Treatments Under InvestigationWith an emphasis on a thorou
"We're in a good place..."
Yahoo Finance